Gender differences in pharmacokinetics of lumefantrine and its metabolite desbutyl-lumefantrine in rats

Biopharmaceutics and Drug Disposition

Volumn 33, Issue 4, 2012, Pages 229-234

  Wahajuddin, ^a   Singh, Sheelendra Pratap ^a   Jain, Girish Kumar ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

desbutyl lumefantrine pharmacokinetics; gender differences; lumefantrine; rats

Indexed keywords

BENFLUMETOL; CYTOCHROME P450 3A; DESBUTYLLUMEFANTRINE; DRUG METABOLITE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BIOAVAILABILITY; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG METABOLISM; FEMALE; MOUSE; NONHUMAN; RAT; SEX DIFFERENCE;

ADMINISTRATION, ORAL; ANIMALS; ANTIMALARIALS; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; CHROMATOGRAPHY, LIQUID; DOSE-RESPONSE RELATIONSHIP, DRUG; ETHANOLAMINES; FEMALE; FLUORENES; INJECTIONS, INTRAVENOUS; MALE; RATS; RATS, SPRAGUE-DAWLEY; SEX FACTORS; TANDEM MASS SPECTROMETRY;

EID: 84861232350     PISSN: 01422782     EISSN: 1099081X     Source Type: Journal    
DOI: 10.1002/bdd.1786     Document Type: Article

References (20)

1. Wilson K,. Sex-related differences in drug disposition in man. Clin Pharmacokinet 1984; 9: 189-202. (Pubitemid 14149062)
2. Harris RZ, Benet LZ, Schwartz JB,. Gender effects in pharmacokinetics and pharmacodynamics. Drugs 1995; 50: 222-239.
3. Davis TM, Karunajeewa HA, Ilett KF,. Artemisinin-based combination therapies for uncomplicated malaria. Med J Aust 2005; 182: 181-185. (Pubitemid 40298186)
4. Denis MB, Tsuyuoka R, Lim P, et al,. Efficacy of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in northwest Cambodia. Trop Med Int Health 2006; 11: 1800-1807. (Pubitemid 44813874)
5. Ezzet F, Mull R, Karbwang J,. Population pharmacokinetics and therapeutic response of CGP 56697 (artemether + benflumetol) in malaria patients. Br J Clin Pharmacol 1998; 46: 553-561. (Pubitemid 28522119)
6. Ezzet F, van Vugt M, Nosten F, Looareesuwan S, White NJ,. Pharmacokinetics and pharmacodynamics of lumefantrine (benflumetol) in acute falciparum malaria. Antimicrob Agents Chemother 2000; 44: 697-704. (Pubitemid 30117964)
7. White NJ, van Vugt M, Ezzet F,. Clinical pharmacokinetics and pharmacodynamics and pharmacodynamics of artemether-lumefantrine. Clin Pharmacokinet 1999; 37: 105-25.
8. Djimde A, Lefevre G,. Understanding the pharmacokinetics of Coartem. Malar J 2009; 8 (Suppl 1): S4.
9. Lefevre G, Carpenter P, Souppart C, et al,. Interaction trial between artemether-lumefantrine (Riamet) and quinine in healthy subjects. J Clin Pharmacol 2002; 42: 1147-1158.
10. Lefevre G, Carpenter P, Souppart C, Schmidli H, McClean M, Stypinski D,. Pharmacokinetics and electrocardiographic pharmacodynamics of artemether-lumefantrine (Riamet) with concomitant administration of ketoconazole in healthy subjects. Br J Clin Pharmacol 2002; 54: 485-492. (Pubitemid 35356874)
11. Wernsdorfer WH,. Coartemether (artemether and lumefantrine): an oral antimalarial drug. Expert Rev Anti Infect Ther 2004; 2: 181-196. (Pubitemid 38735763)
12. Wong RP, Salman S, Ilett KF, Siba PM, Mueller I, Davis TM,. Desbutyl-lumefantrine is a metabolite of lumefantrine with potent in vitro antimalarial activity that may influence artemether-lumefantrine treatment outcome. Antimicrob Agents Chemother 2011; 55: 1194-1198.
13. Yang SH, Yang KH, Lee MG,. Gender differences in ondansetron pharmacokinetics in rats. Biopharm Drug Dispos 2008; 29: 406-413.
14. Hunt CM, Westerkam WR, Stave GM,. Effect of age and gender on the activity of human hepatic CYP3A. Biochem Pharmacol 1992; 44: 275-283.
15. Watkins PB, Murray SA, Winkelman LG, Heuman DM, Wrighton SA, Guzelian PS,. Erythromycin breath-test as an assay of glucocorticoid-inducible liver cytochromes P-450: Studies in rats and patients. J Clin Invest 1989; 83: 688-697. (Pubitemid 19061193)
16. Gorski JC, Jones DR, Haehner-Daniels BD, Hamman MA, O'Mara EM, Hall SD,. The contribution of intestinal and hepatic CYP3A to the interaction between midazolam and clarithromycin. Clin Pharmacol Ther 1998; 64: 133-143. (Pubitemid 28423848)
17. Barbhaiya RH, Buch AB, Greene DS,. A study of the effect of age and gender on the pharmacokinetics of nefazodone after single and multiple doses. J Clin Psychopharmacol 1996; 16: 19-25. (Pubitemid 26060752)
18. Warrington SJ,. Clinical implications of the pharmacology of sertraline. Int Clin Psychopharmacol 1991; 6 (Suppl 2): 11-21.
19. Yukawa E, Mine H, Higuchi S, Aoyama T,. Digoxin population pharmacokinetics from routine clinical data: Role of patient characteristics for estimating dosing regimens. J Pharm Pharmacol 1992; 44: 761-765.
20. Wahajuddin, Singh SP, Raju KS, Nafis A, Puri SK, Jain GK,. Intravenous pharmacokinetics, oral bioavailability, dose proportionality and in situ permeability of anti-malarial lumefantrine in rats. Malar J 2011; 10: 293.